{{Rsnum
|rsid=892515
|Gene=PLCL1
|Chromosome=2
|position=198113097
|Orientation=plus
|GMAF=0.3811
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PLCL1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 43.8 | 47.3 | 8.9
| HCB | 27.2 | 46.3 | 26.5
| JPT | 16.8 | 45.1 | 38.1
| YRI | 75.7 | 19.4 | 4.9
| ASW | 52.6 | 45.6 | 1.8
| CHB | 27.2 | 46.3 | 26.5
| CHD | 25.9 | 49.1 | 25.0
| GIH | 25.7 | 57.4 | 16.8
| LWK | 64.8 | 32.4 | 2.8
| MEX | 29.8 | 52.6 | 17.5
| MKK | 83.2 | 16.1 | 0.6
| TSI | 50.0 | 39.2 | 10.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs892515
|Name_s=
|Gene_s=PLCL1
|Feature=
|Evidence=PubMed ID:18776929
|Annotation=This variant is associated with hip bone size in a genome-wide association study (GWAS) consisting of 1,000 homogeneous unrelated Caucasian subjects.
|Drugs=
|Drug Classes=
|Diseases=Fractures, Bone; Hip Fractures; Hip Injuries; Osteoporosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162316702
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs892515
|overall_frequency_n=46
|overall_frequency_d=126
|overall_frequency=0.365079
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=34
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}